chr6-90516566-G-C
Variant summary
Our verdict is Likely benign. Variant got -6 ACMG points: 0P and 6B. BP4_ModerateBS2
The NM_145331.3(MAP3K7):āc.1756C>Gā(p.Gln586Glu) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0000186 in 1,612,388 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 12/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_145331.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -6 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
MAP3K7 | NM_145331.3 | c.1756C>G | p.Gln586Glu | missense_variant | 17/17 | ENST00000369329.8 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
MAP3K7 | ENST00000369329.8 | c.1756C>G | p.Gln586Glu | missense_variant | 17/17 | 1 | NM_145331.3 | P3 |
Frequencies
GnomAD3 genomes AF: 0.0000198 AC: 3AN: 151838Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000200 AC: 5AN: 250558Hom.: 0 AF XY: 0.0000295 AC XY: 4AN XY: 135424
GnomAD4 exome AF: 0.0000185 AC: 27AN: 1460550Hom.: 0 Cov.: 31 AF XY: 0.0000165 AC XY: 12AN XY: 726602
GnomAD4 genome AF: 0.0000198 AC: 3AN: 151838Hom.: 0 Cov.: 32 AF XY: 0.0000135 AC XY: 1AN XY: 74176
ClinVar
Submissions by phenotype
not provided Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Nov 16, 2023 | This sequence change replaces glutamine, which is neutral and polar, with glutamic acid, which is acidic and polar, at codon 586 of the MAP3K7 protein (p.Gln586Glu). This variant is present in population databases (rs149129500, gnomAD 0.005%). This variant has not been reported in the literature in individuals affected with MAP3K7-related conditions. An algorithm developed to predict the effect of missense changes on protein structure and function (PolyPhen-2) suggests that this variant is likely to be disruptive. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at